RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
1-Year Est. Return
46.93%
1 Year Est. Return
+46.93%
AUM
$5.58B
AUM Growth
+$80.5M
(+1.5%)
Holding
81
Top Buys
| 1 | +$294M | |
| 2 | +$131M | |
| 3 | +$111M | |
| 4 |
Mercury Insurance
MCY
|
+$102M |
| 5 |
New Fortress Energy
NFE
|
+$77.6M |
Top Sells
| 1 | +$251M | |
| 2 | +$96.7M | |
| 3 | +$65.3M | |
| 4 |
Delta Air Lines
DAL
|
+$49M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$48.5M |
Sector Composition
| 1 | Healthcare | 37.06% |
| 2 | Utilities | 27.45% |
| 3 | Energy | 10.46% |
| 4 | Financials | 7.97% |
| 5 | Technology | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLN
1
Talen Energy Corp
TLN
$18.9B
| $1.22B | 21.91% |
6,123,500
|
|
||
2
Teva Pharmaceuticals
TEVA
$22.8B
| $393M | 7.04% |
25,550,000
+8,550,000
|
|
||
3
Golar LNG
GLNG
$3.94B
| $341M | 6.11% |
8,975,149
+1,264,938
|
|
||
4
FTAI Aviation
FTAI
$17.5B
| $294M | 5.26% |
+2,645,000
|
|
||
5
QuidelOrtho
QDEL
$1.95B
| $215M | 3.85% |
6,140,000
+590,000
|
|
||
|
6
New Fortress Energy
NFE
$526M
| $202M | 3.62% |
24,338,675
+9,338,675
|
|
||
7
Roivant Sciences
ROIV
$11.7B
| $179M | 3.21% |
17,767,076
-2,232,924
|
|
||
8
Arcutis Biotherapeutics
ARQT
$2.53B
| $172M | 3.07% |
10,966,672
|
|
||
9
BGC Group
BGC
$4.41B
| $158M | 2.83% |
17,226,380
+250,000
|
|
||
10
TransAlta
TAC
$5.05B
| $112M | 2.01% |
12,000,000
+4,387,337
|
|
||
11
Vistra
VST
$71.4B
| $111M | 1.99% |
+945,969
|
|
||
|
COOP
12
DELISTED
Mr. Cooper
COOP
| $110M | 1.98% |
921,537
-146,143
|
|
||
13
Alight
ALIT
$1.6B
| $105M | 1.88% |
17,720,813
+6,074,134
|
|
||
14
Integra LifeSciences
IART
$1.15B
| $102M | 1.83% |
4,643,672
+2,025,331
|
|
||
|
15
Mercury Insurance
MCY
$4.37B
| $102M | 1.83% |
+1,821,783
|
|
||
16
Adaptive Biotechnologies
ADPT
$2.63B
| $97.5M | 1.75% |
13,117,851
-1,482,149
|
|
||
17
Schrodinger
SDGR
$1.56B
| $94.8M | 1.7% |
4,800,000
-200,000
|
|
||
18
Amneal Pharmaceuticals
AMRX
$3.13B
| $90M | 1.61% |
10,735,977
+14,199
|
|
||
19
Collegium Pharmaceutical
COLL
$1.03B
| $89.5M | 1.6% |
3,000,000
+650,000
|
|
||
20
ReNew
RNW
$2.81B
| $85.6M | 1.53% |
14,527,412
|
|
||
21
Opko Health
OPK
$1.21B
| $80.9M | 1.45% |
48,706,640
|
|
||
22
Kiniksa Pharmaceuticals
KNSA
$2.89B
| $75.1M | 1.35% |
3,383,239
+764,136
|
|
||
|
FLG
23
Flagstar Financial
FLG
$4.74B
| $74.7M | 1.34% |
+6,425,000
|
|
||
24
Liberty Global Class A
LBTYA
$3.77B
| $69.1M | 1.24% |
6,002,651
-592,788
|
|
||
25
Stratasys
SSYS
$999M
| $64.6M | 1.16% |
6,597,333
+406,333
|
|